Virological and clinical characteristics of delta hepatitis in Central Europe

Journal of Viral Hepatitis

Volumn 16, Issue 12, 2009, Pages 883-894

  Heidrich, B ^a   Deterding, K ^a   Tillmann, H L ^a,b   Raupach, R ^a   Manns, M P ^a   Wedemeyer, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Coinfection; Delta hepatitis; Hepatitis B virus; Hepatitis C virus; Hepatitis D virus; Migration medicine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLINESTERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; BLOOD TRANSFUSION; BODY MASS; CHOLINESTERASE BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EASTERN EUROPE; EUROPE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; RNA REPLICATION; SEROLOGY; SEXUALLY TRANSMITTED DISEASE; VIROLOGY; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; GERMANY; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 70449434597     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01144.x     Document Type: Article

References (38)

1. Rizzetto M, Canese MG, Arico S et al. Immunofluorescence detection of new antigen-antibody system (deltaanti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977 18 : 997 1003.
2. Taylor JM. Hepatitis delta virus. Virol 2006 344 : 71 76.
3. Radjef N, Gordien E, Ivaniushina V et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2004 78 : 2537 2544.
4. Su CW, Huang YH, Huo TI et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 2006 130 : 1625 1635.
5. Caturelli E, Castellano L, Fusilli S et al. Coarse nodular US pattern in hepatic cirrhosis: risk for hepatocellular carcinoma. Radiology 2003 226 : 691 697.
6. Farci P. Delta hepatitis: an update. J Hepatol 2003 39 (Suppl 1 S212 S219.
7. Ponzetto A, Forzani B, Parravicini PP, Hele C, Zanetti A, Rizzetto M. Epidemiology of hepatitis delta virus (HDV) infection. Eur J Epidemiol 1985 1 : 257 263.
8. Gaeta GB, Stroffolini T, Chiaramonte M et al. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology 2000 32 : 824 827.
9. Degertekin H, Yalcin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int 2008 28 : 494 498.
10. Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. Hepatitis delta in Europe: vanishing or refreshing? Hepatology 2007 46 : 1312 1313.
11. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection - not a vanishing disease in Europe Hepatology 2007 45 : 1331 1332 author reply 1332-1333.
12. Erhardt A, Knuth R, Sagir A, Kirschberg O, Heintges T, Haussinger D. Socioepidemiological data on hepatitis delta in a German university clinic - increase in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol 2003 41 : 523 526.
13. de Man RA, Sprey RP, Niesters HG et al. Survival and complications in a cohort of patients with anti-delta positive liver disease presenting in a tertiary referral clinic. J Hepatol 1995 23 : 662 667.
14. Wedemeyer H, Pethig K, Wagner D et al. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation 1998 66 : 1347 1353.
15. Tillmann HL, Trautwein C, Bock T et al. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation. Hepatology 1999 30 : 244 256.
16. De Ritis F, Coltorti M, Giusti G. Serum-transaminase activities in liver disease. Lancet 1972 1 : 685 687.
17. Giannini E, Botta F, Testa E et al. The 1-year and 3-month prognostic utility of the ASTALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis. Am J Gastroenterol 2002 97 : 2855 2860.
18. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38 : 518 526.
19. Karoui S, Taieb Jomni M, Bellil K, Haouet S, Boubaker J, Filali A. Predictive factors of fibrosis for chronic viral hepatitis C. Tunis Med 2007 85 : 454 460.
20. Abdo AA, Al Swat K, Azzam N, Ahmed S, Al Faleh F. Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia. Ann Saudi Med 2007 27 : 89 93.
21. Shin WG, Park SH, Jang MK et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis 2008 40 : 267 274.
22. Sakugawa H, Nakasone H, Nakayoshi T et al. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection. J Med Virol 2001 65 : 478 484.
23. Manesis EK, Schina M, Le Gal F et al. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Antivir Ther 2007 12 : 381 388.
24. Werle-Lapostolle B, Bowden S, Locarnini S et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004 126 : 1750 1758.
25. Wursthorn K, Lutgehetmann M, Dandri M et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 2006 44 : 675 684.
26. Shih HH, Jeng KS, Syu WJ et al. Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus. J Virol 2008 82 : 2250 2264.
27. Zachou K, Yurdaydin C, Dienes HP et al. Significance of HDV-RNA and HBsAg levels ind delta hepatitis: first data oft the Hep-NetInternational HDV intervention trial. J Hepatol 2006 44 : 178.
28. Jardi R, Rodriguez F, Buti M et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001 34 : 404 410.
29. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995 22 : 1101 1108.
30. Hung CH, Lee CM, Lu SN et al. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection. J Gastroenterol Hepatol 2005 20 : 727 732.
31. Huo TI, Wu JC, Lee PC et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998 28 : 231 236.
32. Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T-cells. J Virol 2001 75 : 11392 11400.
33. Kanto T, Hayashi N, Takehara T et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999 162 : 5584 5591.
34. Kanto T, Hayashi N. Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity. Intern Med 2006 45 : 183 191.
35. Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J Med Virol 1998 54 : 249 255.
36. Koziel MJ. Cytokines in viral hepatitis. Semin Liver Dis 1999 19 : 157 169.
37. Kubitschke A, Bahr MJ, Aslan N et al. Induction of hepatitis C virus (HCV)-specific T-cells by needle stick injury in the absence of HCV-viraemia. Eur J Clin Invest 2007 37 : 54 64.
38. Raimondo G, Brunetto MR, Pontisso P et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virushepatitis C virus-coinfected patients. Hepatology 2006 43 : 100 107.